Home › Companies › KURA ONCOLOGY INC. › 2024-2025

KURA ONCOLOGY INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and KURA ONCOLOGY INC.’s Form 8-K, filed June 6, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

6Ballot items
181Asset managers
1,222Fund votes
June 5, 2025Meeting date

Results at a glance

Meeting of June 5, 2025: 6 items on KURA ONCOLOGY INC.’s Form 8-K, filed June 6, 2025: 3 approved · 3 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore KURA ONCOLOGY INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by KURA ONCOLOGY INC.

These tallies are KURA ONCOLOGY INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

KURA ONCOLOGY INC. — official shareholder meeting results, meeting held June 5, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Helen Collins, M.D.	55,377,590	--	--	9,392,655	5,864,331	85%	Not verified	—
Elect Director: Thomas Malley	53,300,572	--	--	11,469,673	5,864,331	82%	Not verified	—
Elect Director: Carol Schafer	55,407,228	--	--	9,363,017	5,864,331	86%	Not verified	—
2. Ratification of the Appointment of Independent Registered Public Accounting Firm	70,490,630	72,936	71,010	--	--	99.8%	Approved	—
3. Advisory Vote on Executive Compensation	63,155,796	1,522,754	91,695	--	5,864,331	98%	Approved	—
4. Approval of our Amended 2014 Plan	53,050,063	11,634,755	85,427	--	5,864,331	82%	Approved	—

Source: KURA ONCOLOGY INC., Form 8-K, filed with the SEC on June 6, 2025 — read the filing on EDGAR.

How asset managers voted at the KURA ONCOLOGY INC. 2024-2025 meeting

Each item below shows how the 181 asset managers that disclosed a KURA ONCOLOGY INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Carol Schafer

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%WITHHELD

FOR: 55,407,228WITHHELD: 9,363,017

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of three Class II directors for three-year terms: Carol Schafer

KURA ONCOLOGY INC.’s own tally for this item (“Elect Director: Carol Schafer”): 55,407,228 for, 9,363,017 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 12,948,659 for, 3,015,440 withheld.

FORWITHHOLD

FOR: 12,948,659WITHHOLD: 3,015,440

Largest asset managers voting on “Election of three Class II directors for three-year terms: Carol Schafer” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	4,858,902	0	For
BlackRock	3,761,831	0	For
Fidelity	1,638,027	800	For
State Street	1,618,632	1,866	For
FRANKLIN STRATEGIC SERIES	0	761,091	Withhold
Dimensional	0	684,977	Withhold
Charles Schwab	0	622,972	Withhold
TIAA	233,167	0	For
Equitable	117,367	83,100	Mixed
Exchange Place Advisors Trust	0	193,488	Withhold
Prudential/PGIM	134,347	11,055	Mixed
QUANTITATIVE MASTER SERIES LLC	125,392	0	For
Lincoln Financial	77,446	47,045	Mixed
Putnam	95,013	0	For
PACE SELECT ADVISORS TRUST	0	72,226	Withhold
American Century	0	68,322	Withhold
MASTER INVESTMENT PORTFOLIO	62,429	0	For
Northern Trust	47,274	0	For
Brighthouse	0	46,193	Withhold
Direxion Shares ETF Trust	0	44,590	Withhold
ProShares	0	44,546	Withhold
Global X	0	43,592	Withhold
Voya	39,685	0	For
PFM Multi-Manager Series Trust	0	39,024	Withhold
Harbor ETF Trust	37,944	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

2. Elect Director: Helen Collins, M.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD

FOR: 55,377,590WITHHELD: 9,392,655

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of three Class II directors for three-year terms: Helen Collins, M.D.

KURA ONCOLOGY INC.’s own tally for this item (“Elect Director: Helen Collins, M.D.”): 55,377,590 for, 9,392,655 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 12,948,731 for, 3,015,368 withheld.

FORWITHHOLD

FOR: 12,948,731WITHHOLD: 3,015,368

Largest asset managers voting on “Election of three Class II directors for three-year terms: Helen Collins, M.D.” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	4,858,902	0	For
BlackRock	3,761,831	0	For
Fidelity	1,638,027	800	For
State Street	1,618,632	1,866	For
FRANKLIN STRATEGIC SERIES	0	761,091	Withhold
Dimensional	0	684,977	Withhold
Charles Schwab	0	622,972	Withhold
TIAA	233,167	0	For
Equitable	117,367	83,100	Mixed
Exchange Place Advisors Trust	0	193,488	Withhold
Prudential/PGIM	134,347	11,055	Mixed
QUANTITATIVE MASTER SERIES LLC	125,392	0	For
Lincoln Financial	77,446	47,045	Mixed
Putnam	95,013	0	For
PACE SELECT ADVISORS TRUST	0	72,226	Withhold
American Century	0	68,322	Withhold
MASTER INVESTMENT PORTFOLIO	62,429	0	For
Northern Trust	47,274	0	For
Brighthouse	0	46,193	Withhold
Direxion Shares ETF Trust	0	44,590	Withhold
ProShares	0	44,546	Withhold
Global X	0	43,592	Withhold
Voya	39,685	0	For
PFM Multi-Manager Series Trust	0	39,024	Withhold
Harbor ETF Trust	37,944	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

3. Elect Director: Thomas Malley

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD

FOR: 53,300,572WITHHELD: 11,469,673

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of three Class II directors for three-year terms: Thomas Malley

KURA ONCOLOGY INC.’s own tally for this item (“Elect Director: Thomas Malley”): 53,300,572 for, 11,469,673 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 12,848,871 for, 3,115,228 withheld.

FORWITHHOLD

FOR: 12,848,871WITHHOLD: 3,115,228

Largest asset managers voting on “Election of three Class II directors for three-year terms: Thomas Malley” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	4,858,902	0	For
BlackRock	3,761,831	0	For
Fidelity	1,638,027	800	For
State Street	3,924	1,616,574	Withhold
FRANKLIN STRATEGIC SERIES	761,091	0	For
Dimensional	0	684,977	Withhold
Charles Schwab	622,972	0	For
TIAA	233,167	0	For
Equitable	117,367	83,100	Mixed
Exchange Place Advisors Trust	193,488	0	For
Prudential/PGIM	134,347	11,055	Mixed
QUANTITATIVE MASTER SERIES LLC	125,392	0	For
Lincoln Financial	23,647	100,844	Mixed
Putnam	95,013	0	For
PACE SELECT ADVISORS TRUST	0	72,226	Withhold
American Century	0	68,322	Withhold
MASTER INVESTMENT PORTFOLIO	62,429	0	For
Northern Trust	0	47,274	Withhold
Brighthouse	0	46,193	Withhold
Direxion Shares ETF Trust	0	44,590	Withhold
ProShares	0	44,546	Withhold
Global X	43,592	0	For
Voya	0	39,685	Withhold
PFM Multi-Manager Series Trust	0	39,024	Withhold
Harbor ETF Trust	37,944	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

4. 4. Approval of our Amended 2014 Plan

Official result Fund totals may overlapCOMPENSATIONReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

82% Approved · of votes cast

FOR 82%AGAINST

FOR: 53,050,063AGAINST: 11,634,755

Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: APPROVAL OF AN AMENDMENT TO OUR AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN.

KURA ONCOLOGY INC.’s own tally for this item (“4. Approval of our Amended 2014 Plan”): 53,050,063 for, 11,634,755 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(4) approved our Amended 2014 Plan”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 56 asset managers voting on “APPROVAL OF AN AMENDMENT TO OUR AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN.” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	4,858,902	0	0	For
BlackRock	3,761,831	0	0	For
Fidelity	1,638,027	800	0	For
State Street	1,618,632	1,866	0	For
FRANKLIN STRATEGIC SERIES	761,091	0	0	For
Dimensional	0	684,977	0	Against
Charles Schwab	622,972	0	0	For
TIAA	0	233,167	0	Against
Equitable	117,367	83,100	0	Mixed
Exchange Place Advisors Trust	193,488	0	0	For
Prudential/PGIM	0	145,402	0	Against
QUANTITATIVE MASTER SERIES LLC	125,392	0	0	For
Lincoln Financial	77,446	47,045	0	Mixed
Putnam	0	95,013	0	Against
PACE SELECT ADVISORS TRUST	0	72,226	0	Against
American Century	0	68,322	0	Against
MASTER INVESTMENT PORTFOLIO	62,429	0	0	For
Northern Trust	0	47,274	0	Against
Brighthouse	0	37,874	8,319	Mixed
Direxion Shares ETF Trust	0	44,590	0	Against
ProShares	0	44,546	0	Against
Global X	43,592	0	0	For
Voya	0	39,685	0	Against
PFM Multi-Manager Series Trust	0	39,024	0	Against
Harbor ETF Trust	37,944	0	0	For

Fund voting reports, all 56 managers: 14,042,959 for, 1,912,821 against, 8,319 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “APPROVAL OF AN AMENDMENT TO OUR AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN.” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
ALGERT GLOBAL LLC	216,458	0	0	0	For

Institutional-manager reports, all 1 managers: 216,458 for.

5. 3. Advisory Vote on Executive Compensation

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 63,155,796AGAINST: 1,522,754

Details: description as filed, official tally, votes by 181 asset managers

Description as filed by funds: Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement.

KURA ONCOLOGY INC.’s own tally for this item (“3. Advisory Vote on Executive Compensation”): 63,155,796 for, 1,522,754 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(3) approved, on an advisory basis, the compensation paid to our named executive officers as disclosed in the proxy statement”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports: 56 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	4,858,902	0	0	For
BlackRock	3,761,831	0	0	For
Fidelity	1,638,827	0	0	For
State Street	1,620,083	415	0	For
FRANKLIN STRATEGIC SERIES	761,091	0	0	For
Dimensional	684,977	0	0	For
Charles Schwab	622,972	0	0	For
TIAA	233,167	0	0	For
Equitable	200,467	0	0	For
Exchange Place Advisors Trust	193,488	0	0	For
Prudential/PGIM	145,402	0	0	For
QUANTITATIVE MASTER SERIES LLC	125,392	0	0	For
Lincoln Financial	124,491	0	0	For
Putnam	95,013	0	0	For
PACE SELECT ADVISORS TRUST	72,226	0	0	For
American Century	0	68,322	0	Against
MASTER INVESTMENT PORTFOLIO	62,429	0	0	For
Northern Trust	47,274	0	0	For
Brighthouse	37,874	0	8,319	Mixed
Direxion Shares ETF Trust	44,590	0	0	For
ProShares	44,546	0	0	For
Global X	43,592	0	0	For
Voya	39,685	0	0	For
PFM Multi-Manager Series Trust	39,024	0	0	For
Harbor ETF Trust	37,944	0	0	For

Fund voting reports, all 56 managers: 15,874,895 for, 80,885 against, 8,319 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 147 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Against	Vote
BVF INC/IL	7,754,129	0	For
SUVRETTA CAPITAL MANAGEMENT, LLC	7,452,388	0	For
ARMISTICE CAPITAL, LLC	6,027,476	0	For
RA CAPITAL MANAGEMENT, L.P.	3,957,637	0	For
BlackRock	3,551,308	38,150	For
State Street	3,095,043	625	For
GEODE CAPITAL MANAGEMENT, LLC	1,808,302	0	For
FRANKLIN ADVISERS INC	1,362,871	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	1,076,441	0	For
TCG Crossover Management, LLC	735,184	0	For
Charles Schwab	622,972	0	For
Prosight Management, LP	599,124	0	For
Northern Trust	541,041	0	For
Sofinnova Investments, Inc.	498,846	0	For
Foresite Capital Management IV, LLC	498,015	0	For
DAFNA Capital Management LLC	463,368	0	For
SILVERARC CAPITAL MANAGEMENT, LLC	463,065	0	For
1492 Capital Management LLC	399,803	0	For
AQR	334,650	0	For
JPMorgan	325,702	0	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	258,016	0	For
Russell Investments	254,937	0	For
Voss Capital, LP	249,871	0	For
MELLON INVESTMENTS Corp	244,509	0	For
Nuveen	236,947	0	For

Institutional-manager reports, all 147 managers: 45,455,541 for, 399,259 against, 8,992 not voted. Showing the 25 largest; see all in the interactive database.

6. 2. Ratification of the Appointment of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

99.8% Approved · of votes cast

FOR 99.8%

FOR: 70,490,630AGAINST: 72,936

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2025.

KURA ONCOLOGY INC.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accounting Firm”): 70,490,630 for, 72,936 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(2) ratified the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 15,955,716 for, 64 against, 8,319 abstained.

FOR

FOR: 15,955,716AGAINST: 64ABSTAIN: 8,319

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	4,858,902	0	0	For
BlackRock	3,761,831	0	0	For
Fidelity	1,638,827	0	0	For
State Street	1,620,434	64	0	For
FRANKLIN STRATEGIC SERIES	761,091	0	0	For
Dimensional	684,977	0	0	For
Charles Schwab	622,972	0	0	For
TIAA	233,167	0	0	For
Equitable	200,467	0	0	For
Exchange Place Advisors Trust	193,488	0	0	For
Prudential/PGIM	145,402	0	0	For
QUANTITATIVE MASTER SERIES LLC	125,392	0	0	For
Lincoln Financial	124,491	0	0	For
Putnam	95,013	0	0	For
PACE SELECT ADVISORS TRUST	72,226	0	0	For
American Century	68,322	0	0	For
MASTER INVESTMENT PORTFOLIO	62,429	0	0	For
Northern Trust	47,274	0	0	For
Brighthouse	37,874	0	8,319	Mixed
Direxion Shares ETF Trust	44,590	0	0	For
ProShares	44,546	0	0	For
Global X	43,592	0	0	For
Voya	39,685	0	0	For
PFM Multi-Manager Series Trust	39,024	0	0	For
Harbor ETF Trust	37,944	0	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

Not shown here: this season’s fund filings also report 1 item from the meeting of June 5, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest KURA ONCOLOGY INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 80,778,000 shares outstanding at the time of that meeting.

Fund voting reports: top KURA ONCOLOGY INC. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of our named executive officers, as…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	6.02%
2	BlackRock	4.66%
3	Fidelity	2.03%
4	State Street	2.01%
5	FRANKLIN STRATEGIC SERIES	0.94%
6	Dimensional	0.85%
7	Charles Schwab	0.77%
8	TIAA	0.29%
9	Equitable	0.25%
10	Exchange Place Advisors Trust	0.24%

Institutional-manager reports: top KURA ONCOLOGY INC. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of our named executive officers, as…”, 2024-2025
#	Asset manager	% of shares outstanding
1	BVF INC/IL	9.60%
2	SUVRETTA CAPITAL MANAGEMENT, LLC	9.23%
3	ARMISTICE CAPITAL, LLC	7.46%
4	RA CAPITAL MANAGEMENT, L.P.	4.90%
5	BlackRock	4.44%
6	State Street	3.83%
7	GEODE CAPITAL MANAGEMENT, LLC	2.24%
8	FRANKLIN ADVISERS INC	1.69%
9	JACOBS LEVY EQUITY MANAGEMENT, INC	1.33%
10	TCG Crossover Management, LLC	0.91%

Reported KURA ONCOLOGY INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

KURA ONCOLOGY INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BVF PARTNERS L P/IL	10.74%	13G
BlackRock	10.12%	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	9.36%	13G
Vanguard Group	6.13%	13F
RA Capital Management, L.P.	5.41%	DEF14A
EcoR1 Capital, LLC	5.20%	13G
Armistice Capital, LLC	4.63%	13G
State Street	4.06%	13F
Troy E. Wilson, Ph.D., J.D.	3.48%	DEF14A
Morgan Stanley	2.38%	13F

Percentages above are of 80,778,000 shares outstanding, as reported by KURA ONCOLOGY INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KURA ONCOLOGY INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At KURA ONCOLOGY INC.'s shareholder meeting held June 5, 2025, in the 2024-2025 proxy season, 181 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,222 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of our named executive officers, as… — KURA ONCOLOGY INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: KURA ONCOLOGY INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2025.

KURA ONCOLOGY INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.